Deadline suspensions by intellectual property offices around the world are rapidly coming to a close. Many of these extensions, including in the United States, Brazil, Canada, and other countries, were granted after the COVID-19 pandemic closed governmental offices and served as the basis for unprecedented relief from otherwise firm statutory deadlines for patent and trademark filings. Read more>>
COVID-19 Intellectual Property Extensions Ending in Many Countries; Caution Over Potential Flood of Filings
Intellectual property rights are – by definition – monopolistic. How, then, can researchers, charities and NGOs collaborate with business in the development of new technologies to control and eradicate COVID-19?
Nowadays the sphere of healthcare is becoming one of the mostly discussed because of a mass spread of the coronavirus pandemic (also COVID-19). Confirmed cases of COVID-19 around the world have passed more than a 2.4 million. As the disease is continuing to surge the World Health Organization is warning that there are no specific vaccines or treatments for COVID-19 as for today. However, there are many ongoing clinical trials evaluating potential treatments and developing drugs conducted by different laboratories in developed countries.
April 21, 2020 — As with many government offices and legal institutions across the country, COVID-19, and the resulting workplace shifts, have had an impact on the processing times and delays for procedures passing through the Canadian Intellectual Property Office [CIPO]. Below we will provide a clear overview of the changes to take note of, as well as some interesting COVID-19 related news, that is worth keeping track of.
A few weeks back, as remote working and social distancing were becoming the order of the day (and interesting phrase, given what quickly became the norm in many US states and cities, as executive orders abounded), my son tossed a statement in my direction that was both compliment and challenge: “Isaac Newton developed calculus, among other discoveries and achievements, and Shakespeare may have written King Lear, during quarantine and social distance periods. You’re not them, but you’re pretty smart so I am expecting something.” Offering him this blog post, or some of the other things I have written or said in the last few weeks, is probably not what he had in mind. But it did get me thinking about what intellectual property lawyers and others can do, and have been doing, as we practice law in the time of COVID.
Canada’s COVID-19 Emergency Response Act came into force on March 25, 2020. Perhaps overlooked amongst emergency relief, health care and financial effects is Part 12 of the Act which makes changes to the Patent Act.
Why should the general public care about this? I’m glad you asked.